Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000009.xml
Download PDF
Am J Perinatol 2020; 37(14): 1446-1454
DOI: 10.1055/s-0039-1694007
DOI: 10.1055/s-0039-1694007
Original Article
Low Bioactive Vitamin D Is Associated with Pregnancy-Induced Hypertension in a Cohort of Pregnant HIV-Infected Women Sampled Over a 23-Year Period
Funding This study was supported by SC CTSI (NIH/NCRR/NCATS) through grant number UL1TR000130. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.
Abstract
Objective To examine the association of vitamin D insufficiency and risk of pregnancy-induced hypertension (PIH) among human immunodeficiency virus (HIV)-infected pregnant women.
Study Design This is a retrospective cohort study evaluating the impact of low maternal vitamin D levels on PIH and perinatal outcomes among HIV-infected pregnant women receiving care at an urban HIV center from 1991 to 2014.
Results A total of 366 pregnant women were included, of which 11% developed PIH. Lower levels of 25-hydroxyvitamin D (25(OH)D) and bioactive 1,25-dihydroxyvitamin D (1,25(OH)2D) were associated with increased HIV disease activity. 25(OH)D levels were not significantly associated with the incidence of PIH. Higher 1,25(OH)2D levels were associated with reduced incidence of PIH in univariate (odds ratio, OR: 0.87 [95% confidence interval, CI: 0.79–0.95], p = 0.004) and multivariate (OR: 0.88 [95% CI: 0.80–0.97], p = 0.010) analyses. No association was found between 25(OH)D levels and other obstetric outcomes. Lower 1,25(OH)2D levels were associated with group B Streptococcus colonization (OR: 0.92 [95% CI: 0.86–0.99]) and low birth weight (LBW) (OR: 0.90 [95% CI: 0.83–0.98]) on multivariate analysis. Mean 1,25(OH)2D levels were significantly lower in women with preterm delivery and LBW infants.
Conclusion Lower bioactive vitamin D levels are related to PIH in HIV-infected women. This association may be related to the coexistence of abnormal placental vitamin D metabolism and abnormal placental implantation.
Keywords
pregnancy - hypertension - preeclampsia - pregnancy-induced hypertension - vitamin D - human immunodeficiency virusPublication History
Received: 28 April 2019
Accepted: 25 June 2019
Article published online:
31 July 2019
© 2020. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 ACOG practice bulletin no. 202: gestational hypertension and preeclampsia. Obstet Gynecol 2019; 133 (01) e1-e25
- 2 Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011; 25 (04) 391-403
- 3 The American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122 (05) 1122-1131
- 4 Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens 2008; 21 (05) 521-526
- 5 Roberts JM, Escudero C. The placenta in preeclampsia. Pregnancy Hypertens 2012; 2 (02) 72-83
- 6 Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998; 179 (05) 1359-1375
- 7 Reitter A, Stücker AU, Linde R. et al. Pregnancy complications in HIV-positive women: 11-year data from the Frankfurt HIV cohort. HIV Med 2014; 15 (09) 525-536
- 8 Stoner MC, Vwalika B, Smid MC. et al. A retrospective study of HIV, antiretroviral therapy, and pregnancy-associated hypertension among women in Lusaka, Zambia. Int J Gynaecol Obstet 2016; 134 (03) 299-303
- 9 Canlorbe G, Matheron S, Mandelbrot L, Oudet B, Luton D, Azria E. Vasculoplacental complications in pregnant women with HIV infection: a case-control study. Am J Obstet Gynecol 2015; 213 (02) 241.e1-241.e9
- 10 Browne JL, Schrier VJ, Grobbee DE, Peters SA, Klipstein-Grobusch K. HIV, antiretroviral therapy, and hypertensive disorders in pregnancy: a systematic review and meta-analysis. J Acquir Immune Defic Syndr 2015; 70 (01) 91-98
- 11 Machado ES, Krauss MR, Megazzini K. et al; NICHD International Site Development Initiative (NISDI) Pediatric Protocol. Hypertension, preeclampsia and eclampsia among HIV-infected pregnant women from Latin America and Caribbean countries. J Infect 2014; 68 (06) 572-580
- 12 Ewing AC, Datwani HM, Flowers LM, Ellington SR, Jamieson DJ, Kourtis AP. Trends in hospitalizations of pregnant HIV-infected women in the United States: 2004 through 2011. Am J Obstet Gynecol 2016; 215 (04) 499.e1-499.e8
- 13 Katz DL, Friedman RS, Lucan SC. Nutrition in Clinical Practice, 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2015
- 14 Heaney RP, Weaver CM. ; IOM (Institute of Medicine). Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press; 2011
- 15 Brannon PM, Picciano MF. Vitamin D in pregnancy and lactation in humans. Annu Rev Nutr 2011; 31: 89-115
- 16 Christakos S, Hewison M, Gardner DG. et al. Vitamin D: beyond bone. Ann N Y Acad Sci 2013; 1287 (01) 45-58
- 17 Ganguly A, Tamblyn JA, Finn-Sell S. et al. Vitamin D, the placenta and early pregnancy: effects on trophoblast function. J Endocrinol 2018; 236 (02) R93-R103
- 18 Equils O, Hewison M. A role for vitamin D in placental immunology. J Infect Dis 2010; 201 (12) 1950-1951
- 19 Chan SY, Susarla R, Canovas D. et al. Vitamin D promotes human extravillous trophoblast invasion in vitro. Placenta 2015; 36 (04) 403-409
- 20 Mansueto P, Seidita A, Vitale G, Gangemi S, Iaria C, Cascio A. Vitamin D deficiency in HIV infection: not only a bone disorder. BioMed Res Int 2015; 2015: 735615
- 21 Adeyemi OM, Agniel D, French AL. et al. Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. J Acquir Immune Defic Syndr 2011; 57 (03) 197-204
- 22 Mueller NJ, Fux CA, Ledergerber B. et al; Swiss HIV Cohort Study. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS 2010; 24 (08) 1127-1134
- 23 Jiménez-Sousa MA, Martínez I, Medrano LM, Fernández-Rodríguez A, Resino S. Vitamin D in human immunodeficiency virus infection: influence on immunity and disease. Front Immunol 2018; 9 (MAR): 458
- 24 Haug CJ, Aukrust P, Haug E, Mørkrid L, Müller F, Frøland SS. Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab 1998; 83 (11) 3832-3838
- 25 Mehta S, Giovannucci E, Mugusi FM. et al. Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS One 2010; 5 (01) e8770
- 26
Mehta S,
Hunter DJ,
Mugusi FM.
et al. Perinatal outcomes, including mother-to-child transmission of HIV, and child
mortality and their association with maternal vitamin D status in Tanzania. J Infect
Dis 2009; 200 (07) 1022-1030
MissingFormLabel
- 27 von Websky K, Hasan A, Reichetzeder C, Tsuprykov O, Hocher B. Impact of vitamin D on pregnancy-related disorders and on offspring outcome. J Steroid Biochem Mol Biol 2018; 180: 51-64
- 28
Bearden A,
Van Winden K,
Kono N.
et al.
Low Vitamin D is Associated with Mother-to-Child-Transmission (MTCT) of Cytomegalovirus
(CMV) in Women with HIV. In: Infectious Disease Society of America Annual Meeting,
New Orleans, LA; October 26–30, 2016
MissingFormLabel
- 29 Yun C, Chen J, Yang C, Li Y, Piao J, Yang X. Comparison of two 25-hydroxyvitamin D immunoassays to liquid chromatography-tandem mass spectrometry in assessing samples from the Chinese population. Clin Chim Acta 2015; 448 (29) 22-26
- 30 Seiden-Long I, Vieth R. Evaluation of a 1,25-dihydroxyvitamin D enzyme immunoassay. Clin Chem 2007; 53 (06) 1104-1108
- 31 Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011; 26 (10) 2341-2357
- 32 Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357 (03) 266-281
- 33 Finkelstein JL, Mehta S, Duggan C. et al. Maternal vitamin D status and child morbidity, anemia, and growth in human immunodeficiency virus-exposed children in Tanzania. Pediatr Infect Dis J 2012; 31 (02) 171-175
- 34 Kiely ME, Zhang JY, Kinsella M, Khashan AS, Kenny LC. Vitamin D status is associated with uteroplacental dysfunction indicated by pre-eclampsia and small-for-gestational-age birth in a large prospective pregnancy cohort in Ireland with low vitamin D status. Am J Clin Nutr 2016; 104 (02) 354-361
- 35 Mirzakhani H, Litonjua AA, McElrath TF. et al. Early pregnancy vitamin D status and risk of preeclampsia. J Clin Invest 2016; 126 (12) 4702-4715
- 36 Purswani JM, Gala P, Dwarkanath P, Larkin HM, Kurpad A, Mehta S. The role of vitamin D in pre-eclampsia: a systematic review. BMC Pregnancy Childbirth 2017; 17 (01) 231
- 37 Powe CE, Seely EW, Rana S. et al. First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia. Hypertension 2010; 56 (04) 758-763
- 38 De-Regil LM, Palacios C, Lombardo LK, Peña-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev 2016; (01) CD008873
- 39 Palacios C, De-Regil LM, Lombardo LK, Peña-Rosas JP. Vitamin D supplementation during pregnancy: updated meta-analysis on maternal outcomes. J Steroid Biochem Mol Biol 2016; 164: 148-155
- 40 Behjat Sasan S, Zandvakili F, Soufizadeh N, Baybordi E. The effects of vitamin D supplement on prevention of recurrence of preeclampsia in pregnant women with a history of preeclampsia. Obstet Gynecol Int 2017; 2017: 8249264
- 41 Viard J-P, Souberbielle J-C, Kirk O. et al; EuroSIDA Study Group. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS 2011; 25 (10) 1305-1315
- 42 Bearden A, Abad C, Gangnon R, Sosman JM, Binkley N, Safdar N. Cross-sectional study of vitamin D levels, immunologic and virologic outcomes in HIV-infected adults. J Clin Endocrinol Metab 2013; 98 (04) 1726-1733
- 43 Aghajafari F, Field CJ, Kaplan BJ. et al; APrON Study Team. The current recommended vitamin D intake guideline for diet and supplements during pregnancy is not adequate to achieve vitamin D sufficiency for most pregnant women. PLoS One 2016; 11 (07) e0157262
- 44 WHO. Guideline: Vitamin D Supplementation in Pregnant Women. Geneva, Switzerland: World Health Organization; 2012
- 45 The American College of Obstetricians and Gynecologists, American Academy of Pediatrics. Guidelines for Perinatal Care, 8th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2017
- 46 Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011; 26 (10) 2341-2357
- 47 Wagner CL, McNeil R, Hamilton SA. et al. A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am J Obstet Gynecol 2013; 208 (02) 137.e1-137.e13
- 48 Roth DE, Leung M, Mesfin E, Qamar H, Watterworth J, Papp E. Vitamin D supplementation during pregnancy: state of the evidence from a systematic review of randomised trials. BMJ 2017; 359: j5237
- 49 Hollis BW, Wagner CL. New insights into the vitamin D requirements during pregnancy. Bone Res 2017; 5 (April): 17030